Table 4.
FDA approved drugs from 2017–2019.
| Drug | Year approved |
|---|---|
| Gemtuzumab Ozogamicin (GO) | 2017 |
| CPX-351 (Vyxeos) | 2017 |
| Midostaurin | 2017 |
| Enasidenib | 2017 |
| Venetoclax | 2018 |
| Glasdegib | 2018 |
| Ivosidenib | 2018 |
| Gilteritinib | 2019 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.